Management

Gualberto Ruaño, M.D., Ph.D., President and Chief Executive Officer. Dr. Ruaño has been an entrepreneur in the biotechnology industry for 20 years, and is a pioneer in the technology and business of personalized medicine. Previously, he founded Genaissance Pharmaceuticals in 1997 as the pioneer company in pharmacogenomics, and served as CEO and as Chief Scientific Officer. As CEO, he raised $60 million of private equity, led the company’s $90 million IPO in 2000, and negotiated R&D partnerships with major pharmaceutical and biotechnology companies. As CSO of Genaissance, Dr. Ruaño developed fundamental technology for genetic associations based on gene haplotypes. Prior to that, as co-founder of BIOS Laboratories since 1992, he invented the Coupled Amplification and Sequencing System (U.S. patent 5,427,911) for the rapid determination of sequence variation, which is marketed worldwide by Siemens Healthcare Diagnostics as TRUGENE™ and was the first pharmacogenomic diagnostic system approved by the FDA. Dr. Ruaño is a founding Director of the Personalized Medicine Coalition in Washington, D.C. and is senior editor of the journal Personalized Medicine (London). He has served on steering committees working with the FDA on pharmacogenomic guidelines and as a member at the Manhattan Institute's 21st Century FDA Task Force. Dr. Ruaño also serves on advisory committees of the National Academy of Clinical Biochemistry instituting guidelines for pharmacogenetic testing in the clinical laboratory. He has an M.D. and PhD. from Yale University and a B.A. from Johns Hopkins University (Phi Beta Kappa). Dr. Ruaño is also Director of Genetics Research at Hartford Hospital and holds Adjunct Professorships on the medical faculties at George Washington University and the University of Puerto Rico. He is a Fellow of the National Academy of Clinical Biochemistry and of the American Institute for medical and Biological Engineering. He is also a trustee of the Wadsworth Atheneum Museum of Art and of the Bushnell Center for the Performing Arts in Hartford.

Robert W. Scherrer, Chief Financial Officer. Mr. Scherrer has more than 40 years experience in financial and operations management in both large and small companies. From 1999 to 2002, Mr. Scherrer served as SVP and COO of Freshnex, Inc., an internet trading network, where he was a major contributor in the building of the Company and completion of its three venture-backed financing rounds. Prior to that, he was President and COO of Protein Sciences Corporation, a biotechnology company, from 1994 to 1998 and CFO from 1991 to 1994. Prior to joining Protein Sciences, Mr. Scherrer was the CFO of Richardson-Vicks USA, a $600 million subsidiary of The Procter & Gamble Company. He holds a BS degree in Finance from the Temple University Fox School of Business and Management.

Andreas Windemuth, Ph.D., Chief Technology Officer. Dr. Windemuth is Chief Technology Officer of Genomas and co-inventor with Dr. Ruaño in the various patents of the company. Dr. Windemuth has worked in the field of computational biology for 15 years. Previously, Dr. Windemuth was Senior Director of Computational Research and Development at Genaissance Pharmaceuticals, Inc., where he was instrumental in the development of the haplotype sequencing technology. Dr. Windemuth started his biotechnology career at CuraGen Corp. (New Haven, CT), where he was instrumental in developing many of the company's genomic technologies. Dr. Windemuth is a fellow of the Boehringer Ingelheim Fonds (Stuttgart, Germany). He obtained his Ph.D. in Theoretical Physics from the Technical University of Munich.

Teresa Giuliano, Sales Director. Mrs. Giuliano has 25 years of extensive experience in pharmaceutical sales. Most recently a neuroscience specialty sales representative for Innovex, Inc. (Morrisville, NC), she had responsibility for promotion of Zyprexa® and Strattera® to psychiatrists in Connecticut. Prior to that, Mrs. Giuliano served as a District manager for Diopsys, Inc (Pinebrook, NJ) with responsibility for the introduction of a new vision medical device technology in New England. Priorly, she held sales positions of increasing responsibility with Serono, Inc, (Rockland, MA) as Key Account Manager for neurology drugs and Bristol-Myers Squibb (New York, NY) as Institutional Neuroscience Specialist. She holds a BS degree in Marketing from the University of Connecticut.

Board of Directors

Steven D. Hanks, M.D., MMM FACP. Dr. Hanks is Senior VP, Medical Affairs & Chief Medical Officer of the Central Connecticut Health Alliance in New Britain, CT. He is a Fellow, American College of Physicians, and a Delegate to the Connecticut State Medical Society. Dr. Hanks serves on the Boards of the Connecticut Medical Examining Board, the Biomedical Engineering Alliance & Consortium and is Vice Chair, Medical Liability Mutual Insurance Company Defense Board. He holds a Masters Degree in Medical Management from Carnegie Mellon University and received his M.D. with Distinction in Research from the University of Rochester.

William C. Popik, M.D. Dr. Popik is SVP and Chief Medical Officer of Lifemasters Supported Health Care Inc., a privately held disease management company. Previously, Dr. Popik served as the Chief Medical Officer at Aetna, Inc. where he was part of the senior team that was responsible for the successful financial turnaround of the company. Prior to working for Aetna, he served as SVP and national medical director at CIGNA Healthcare Inc. He serves on several boards, including the American Diabetes Association, Darwin Professional Underwriters, Inc (DR), and Connecticut Childrens' Medical Center, and is chairman of the Disease Management Association of America.

David M. Roth, M.A, J.D. Mr. Roth is a principal and managing director of WLD Enterprises, Inc., a private investment vehicle. Prior to his full-time involvement with WLD Enterprises, Inc., he was a partner in the Connecticut law firm of Levy & Droney, P.C. He serves as a Trustee of Lafayette College in Pennsylvania and the Progressive Policy Institute in Washington, DC. Additionally, he serves as a Director to the Romanian-American Enterprise Fund and is the President of the Board of Directors of the Hartford Symphony Orchestra. He serves as a member of the Investment Committee of the Jewish Community Foundation, and the Investment Advisory Council, Office of the Treasurer, State of Connecticut.

Gualberto Ruaño, M.D., Ph.D. Dr. Ruaño is Chairman of the Board of Directors.

Abdón G. Ruiz. Mr. Ruiz is Co-Founder and Managing Director of Miradero Capital Partners, San Juan, Puerto Rico, a private equity investment firm whose investors include the Government of Puerto Rico, the leading financial institutions on the Island, prominent local corporations and high net worth individuals. Prior to his current position, Mr. Ruiz was Director of the Venture Capital Division of the Economic Development Bank for Puerto Rico (EDB). Mr. Ruiz has been a member of the Board of Directors of a number of portfolio companies including Aeromed Medical Services and Pharmaceutical Packaging Specialties.

Victor Villagra, M.D., FACP. Dr. Villagra, President of Health & Technology Vector, Inc. is an independent heath care consultant with extensive experience in managed care, disease management and technology assessment. He previously served as National Medical Director and VP Quality & Medical Strategy at CIGNA HealthCare.

Joaquín B. Viso, M.S. Mr. Viso is Chairman and CEO of Alara Pharmaceutical Corporation and Orbix HealthCare Corporation, firms dedicated, respectively to develop pharmaceutical products and to provide pharmacy benefits management services to health insurance providers. Previously, he was President and CEO of Mova Pharmaceutical Corporation, a company he founded in 1986 that was acquired by Patheon, Inc. in 2004. Prior to that, he was President and General Manager of SmithKline (now Glaxo SmithKline) operations in Puerto Rico. He is a member of the Board of Directors of Patheon Inc., Universidad Central del Caribe and Scotiabank of Puerto Rico. Mr. Viso has been recognized in Puerto Rico as an outstanding representative of Puerto Rico's entrepreneurial achievement and contributor to economic development, and was named "Businessman of the Year" by the U.S. Hispanic Chamber of Commerce in 1999.

Medical Advisors

Bruce Bower, M.D., Senior Clinical Consultant. Dr. Bower is a clinical consultant to pharmaceutical companies. He also holds the position of Clinical Professor of Medicine at the University of Connecticut, School of Medicine. Most recently he held the position of Chief, Diabetes & Endocrinology Division, Hartford Hospital where he provided overall management and strategic direction to 12-member department of Endocrinology and managed the Endocrine Fellowship teaching program in junction with the University of Connecticut. Dr. Bower received the Distinction in Clinical Endocrinology from the American Association of Clinical Endocrinologists in 2004 and Distinguished Clinician from the American Diabetes Association in 2000.

Theodore Holford, Ph.D., Senior Biostatistical Consultant. Dr. Holford is Susan Dwight Bliss Professor of Public Health (Biostatistics), Professor of Statistics and Head of the Division of Biostatistics at Yale University School of Medicine. The fields in which he has collaborated and used his methods include cancer epidemiology, perinatal epidemiology, environmental health sciences, spinal cord injury studies, psychiatry, geriatrics and pediatrics. He is one of the founding editors of Statistical Methods in Medical Research. In addition, he is the author of Multivariate Methods in Epidemiology (Oxford University Press 2002), a textbook and standard reference on statistical methods in epidemiological research. In addition, he has made significant methodological contributions to multivariate analysis of matched studies, log-linear models for survival, analysis of time trends for disease, and population models for disease trends.